Sol Steinberg is an expert consultant specializing in OTC derivatives markets, including practices relating to regulation, risk management, market structure, collateral, valuation, and financial technology systems. Sol is the founding partner of his firm 'OTC Partners', which is a boutique value add firm based in New York that specialises in research, content, and business development. OTC Partners has developed a number of leading research reports covering global capital markets, has advised central banks on market dynamics in Singapore, Chile, Peru, Mexico, and Colombia , as well as helping to spearhead the evolution of Chinese OTC derivatives markets in Beijing, Jinan, Quango, and Shenzhen. Sol's extensive professional experience encompasses a senior executive position at LCH.Clearnet and nearly a decade of OTC derivatives product development, risk management, and valuation for Citi. Sol has successfully commercialised data and analytics tools (e.g. SMART tool, Risk Explorer, Global Market Risk, CCP2) and has gained a number of prestigious globally recognised industry awards in the process.